ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
oxxa23
|
15K |
7.1M |
8 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
15K
|
7.1M
|
8
|
|
ASX - By Stock
|
ALA |
Re:
Ann: Trading Halt
|
|
oxxa23
|
32 |
14K |
0 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
32
|
14K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
oxxa23
|
15K |
7.1M |
4 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
15K
|
7.1M
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
oxxa23
|
15K |
7.1M |
5 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
15K
|
7.1M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
oxxa23
|
15K |
7.1M |
5 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
15K
|
7.1M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
oxxa23
|
54 |
18K |
6 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
54
|
18K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
oxxa23
|
15K |
7.1M |
16 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
15K
|
7.1M
|
16
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
oxxa23
|
54 |
18K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
54
|
18K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
oxxa23
|
15K |
7.1M |
28 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
15K
|
7.1M
|
28
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
oxxa23
|
15K |
7.1M |
10 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
15K
|
7.1M
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
oxxa23
|
15K |
7.1M |
20 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
15K
|
7.1M
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
oxxa23
|
15K |
7.1M |
43 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
15K
|
7.1M
|
43
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
oxxa23
|
54 |
18K |
2 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
54
|
18K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update
|
|
oxxa23
|
30 |
19K |
27 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
30
|
19K
|
27
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
oxxa23
|
54 |
18K |
2 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
54
|
18K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
oxxa23
|
54 |
18K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
54
|
18K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
oxxa23
|
15K |
7.1M |
24 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
15K
|
7.1M
|
24
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
oxxa23
|
4.2K |
3.8M |
2 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
oxxa23
|
4.4K |
2.0M |
9 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
oxxa23
|
4.2K |
3.8M |
2 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
oxxa23
|
4.2K |
3.8M |
7 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4.2K
|
3.8M
|
7
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
oxxa23
|
670 |
260K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
670
|
260K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
oxxa23
|
670 |
260K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
670
|
260K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
oxxa23
|
670 |
260K |
11 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
670
|
260K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Board Changes
|
|
oxxa23
|
48 |
18K |
3 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
48
|
18K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Board Changes
|
|
oxxa23
|
48 |
18K |
2 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
48
|
18K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Board Changes
|
|
oxxa23
|
48 |
18K |
9 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
48
|
18K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Initial Director's Interest Notice
|
|
oxxa23
|
13 |
3.8K |
2 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
13
|
3.8K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Initial Director's Interest Notice
|
|
oxxa23
|
13 |
3.8K |
8 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
13
|
3.8K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Board Changes
|
|
oxxa23
|
48 |
18K |
13 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
48
|
18K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Board Changes
|
|
oxxa23
|
48 |
18K |
12 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
48
|
18K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Employee Performance Rights Plan Issue
|
|
oxxa23
|
12 |
3.2K |
5 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
12
|
3.2K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Employee Performance Rights Plan Issue
|
|
oxxa23
|
12 |
3.2K |
2 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
12
|
3.2K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Employee Performance Rights Plan Issue
|
|
oxxa23
|
12 |
3.2K |
5 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
12
|
3.2K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Employee Performance Rights Plan Issue
|
|
oxxa23
|
12 |
3.2K |
3 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
12
|
3.2K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
How would involvement from a Venture capitalists or Private equity group look for Paradigm
|
|
oxxa23
|
59 |
18K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
59
|
18K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Half Yearly Report and Accounts
|
|
oxxa23
|
37 |
13K |
7 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
37
|
13K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Half Yearly Report and Accounts
|
|
oxxa23
|
37 |
13K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
37
|
13K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
How would involvement from a Venture capitalists or Private equity group look for Paradigm
|
|
oxxa23
|
59 |
18K |
7 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
59
|
18K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
oxxa23
|
92 |
41K |
0 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
92
|
41K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Video: Paradigm Biopharmaceuticals (ASX:PAR) conducting Phase 3 osteoarthritis trial
|
|
oxxa23
|
31 |
10K |
5 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
31
|
10K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Video: Paradigm Biopharmaceuticals (ASX:PAR) conducting Phase 3 osteoarthritis trial
|
|
oxxa23
|
31 |
10K |
8 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
31
|
10K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Video: Paradigm Biopharmaceuticals (ASX:PAR) conducting Phase 3 osteoarthritis trial
|
|
oxxa23
|
31 |
10K |
7 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
31
|
10K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Video: Paradigm Biopharmaceuticals (ASX:PAR) conducting Phase 3 osteoarthritis trial
|
|
oxxa23
|
31 |
10K |
7 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
31
|
10K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Video: Paradigm Biopharmaceuticals (ASX:PAR) conducting Phase 3 osteoarthritis trial
|
|
oxxa23
|
31 |
10K |
3 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
31
|
10K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
oxxa23
|
327 |
108K |
4 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
327
|
108K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
oxxa23
|
327 |
108K |
1 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
327
|
108K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
oxxa23
|
327 |
108K |
7 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
327
|
108K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
oxxa23
|
327 |
108K |
2 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
327
|
108K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
oxxa23
|
327 |
108K |
4 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
327
|
108K
|
4
|
|